의약품 관련 법령
Questions and Answers on Biosimilar Development and the BPCI Act
| 작성자 | 관리자 | ||
|---|---|---|---|
| 작성일 | 2018-12-13 | 조회수 | 1,085 |
| 국가정보 | 북 아메리카>미국 | ||
| 출처 | FDA | ||
| 원문 | https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm290967.htm | ||
| 첨부파일 | |||
UCM444661.pdf(342.59KB)
Questions and Answers on Biosimilar Development and the BPCI Act
- 이전글 Noncirrhotic Nonalcoholic Steatohepatitis With Liver Fibrosis: Developing Drugs for Treatment
- 다음글 New and Revised Draft Q&As on Biosimilar Development and the BPCI Act (Revision 2)
